Following a merger and subsequent spin-off, the website now serves as a portal for Keenova Therapeutics and Par Health. Keenova focuses on specialty therapeutics for rare or unaddressed conditions in fields such as immunology and urology. Par Health manufactures and develops generic pharmaceuticals, sterile injectables, and active pharmaceutical ingredients.
AI named Endo International in September 2026.
Brand page for endo-com